Grant ID DP200081
Awarded On August 19, 2020
Title Image-guided Surgical Detection of Metastatic Disease to the Peritoneum, Lymph Nodes and Pleural Surfaces
Program Product Development Research
Award Mechanism Texas Company Product Development Awards
Institution/Organization OncoNano Medicine
Principal Investigator/Program Director Ravi Srinivasan
Cancer Sites All Sites
Contracted Amount $9,965,273*

*Pending contract negotiation

Lay Summary

OncoNano Medicine, Inc., a spinout of UT Southwestern headquartered in Southlake, TX, developed its first product, ONM-100, for imaging cancer with the help of a $6 million CPRIT NEWCO award in 2014. ONM-100 was granted a Fast Track designation and is currently in Phase 2 trials. These initial clinical trials continue to successfully demonstrate the use of ONM-100 in imaging cancer tumors. OncoNano has discovered that ONM-100 can also be used to image and stage metastatic disease in the peritoneum, lymph nodes and pleura resulting from gastric, colorectal, prostate, ovarian, lung, and breast cancers. This important and valuable advance meets a critical unmet need for cancer patients. Today, ...

Read More